PHI with Hanot-Roessle syndrome
How does this condition affect your private health insurance?
Hanot-Roessle-Syndrom, now known as Primary Biliary Cholangitis (PBC), is a chronic, progressive autoimmune disease primarily affecting the liver's small bile ducts. The immune system mistakenly attacks these ducts, leading to their destruction and impaired bile flow (cholestasis). This accumulation of bile causes inflammation, scarring (fibrosis), and eventually cirrhosis and liver failure. Symptoms often include debilitating fatigue, intense itching (pruritus), and dry eyes/mouth, typically progressing slowly over years. It predominantly affects middle-aged women. Diagnosis involves specific blood tests and liver biopsy. Treatment aims to slow disease progression and manage symptoms, with liver transplant being an option for advanced cases.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Insidious onset, often years before diagnosis; initial vague symptoms like fatigue or itching can be chronic and persistent.
Duration of Illness (Lifetime)
Chronic, progressive, life-long condition requiring continuous management; may eventually lead to end-stage liver disease.
Cost of Treatment (Initial)
Diagnostic costs (blood tests, imaging, liver biopsy) can range from several hundreds to a few thousands USD. Initial medication (e.g., ursodeoxycholic acid) is ongoing.
Cost of Treatment (Lifetime)
Significantly high. Includes lifelong medication (e.g., UDCA, obeticholic acid), regular specialist visits, management of complications (e.g., bone disease, varices), and potential liver transplantation (hundreds of thousands to over a million USD).
Mortality Rate
Significant if untreated or if disease progresses to end-stage liver failure. Effective treatment, particularly with UDCA, can significantly improve survival and delay progression, but it is not a cure.
Risk of Secondary Damages
High. Progression to cirrhosis, portal hypertension, liver failure, osteoporosis/osteopenia, malabsorption of fat-soluble vitamins, gallstones, and increased risk of hepatocellular carcinoma. Psychological impact includes chronic fatigue and depression.
Probability of Full Recovery
Extremely low. PBC is a chronic, progressive autoimmune disease with no known cure. Treatment focuses on slowing progression, managing symptoms, and preventing complications.
Underlying Disease Risk
Moderately high. Frequently co-occurs with other autoimmune conditions such as Sjögren's syndrome, autoimmune thyroid disease, rheumatoid arthritis, and scleroderma.